HEMATOPOETIC STEM CELL TRANSPLANTATION WITH CURRENT PERSPECTIVE IS SAFE FOR MUCOPOLYSACCHARIDOSIS TYPE VI PATIENTS

Sadeleştirilmiş öğe sayfası
dc.contributor.authorUygun, Vedat
dc.contributor.authorKarasu, Gulsun
dc.contributor.authorYalcin, Koray
dc.contributor.authorOzturkmen, Seda
dc.contributor.authorCelen, Safiye Suna
dc.contributor.authorDaloglu, Hayriye
dc.contributor.authorZhumatayev, Suleimen
dc.contributor.authorYesilipek, Akif
dc.date.accessioned2025-10-16T15:12:36Z
dc.date.issued2024
dc.description.abstract50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Glasgow, SCOTLAND, APR 14-17, 2024
dc.identifier.otherWOS:001365375002060
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5519
dc.publisherSPRINGERNATURE
dc.sourceBONE MARROW TRANSPLANTATION
dc.titleHEMATOPOETIC STEM CELL TRANSPLANTATION WITH CURRENT PERSPECTIVE IS SAFE FOR MUCOPOLYSACCHARIDOSIS TYPE VI PATIENTS
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS